| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 73,1 M € | +21.1% | 60,3 M € | +5.8% | 57,0 M € | +6.7% | 53,5 M € | +33.0% | 40,2 M € | -17.1% | 48,5 M € | +11.3% | 43,6 M € | +31.4% | 33,2 M € | +69.0% | 19,6 M € | +181.9% | 7,0 M € | -6.3% | 7,4 M € | +18.7% | 6,3 M € | +6.3% | 5,9 M € | +35.6% | 4,3 M € | |
| EBITDA | 2,5 M € | +67.4% | 1,5 M € | -23.1% | 1,9 M € | +136.3% | 815,7 k € | +23.9% | 658,3 k € | -47.6% | 1,3 M € | -46.4% | 2,3 M € | +35.0% | 1,7 M € | +12.4% | 1,5 M € | +235.4% | 460,8 k € | -18.1% | 562,8 k € | +128.8% | 246,0 k € | -26.4% | 334,3 k € | +5.6% | 316,7 k € | |
| Operating profit | 3,1 M € | +181.5% | 1,1 M € | -45.2% | 2,0 M € | +76.0% | 1,1 M € | +31.3% | 873,2 k € | -28.2% | 1,2 M € | -33.8% | 1,8 M € | +22.2% | 1,5 M € | -2.1% | 1,5 M € | +228.8% | 466,5 k € | -1.7% | 474,4 k € | +128.9% | 207,3 k € | -25.2% | 276,9 k € | -11.2% | 311,7 k € | |
| Profit/loss | 2,4 M € | +201.8% | 795,7 k € | -46.3% | 1,5 M € | +75.6% | 843,8 k € | +55.9% | 541,2 k € | -35.6% | 840,0 k € | -30.9% | 1,2 M € | +24.5% | 977,3 k € | -11.0% | 1,1 M € | +275.7% | 292,3 k € | +1.4% | 288,3 k € | +122.9% | 129,3 k € | -41.7% | 221,7 k € | +13.9% | 194,6 k € | |
| Equity | 27,0 M € | +9.8% | 24,5 M € | +3.3% | 23,8 M € | +6.7% | 22,3 M € | +3.9% | 21,4 M € | +2.6% | 20,9 M € | +4.2% | 20,0 M € | +6.5% | 18,8 M € | +5.5% | 17,9 M € | +2.2% | 17,5 M € | -26.8% | 23,9 M € | -0.0% | 23,9 M € | 0.0% | 23,9 M € | 0.0% | 23,9 M € | |
| Total assets | 43,9 M € | +14.5% | 38,3 M € | +2.9% | 37,2 M € | +17.0% | 31,8 M € | -1.3% | 32,2 M € | -15.3% | 38,0 M € | -2.1% | 38,8 M € | +15.7% | 33,6 M € | +1.9% | 32,9 M € | +25.4% | 26,3 M € | -0.3% | 26,3 M € | -0.2% | 26,4 M € | +3.1% | 25,6 M € | +1.9% | 25,1 M € | |
| Cash | 25,2 k € | +181.9% | 8,9 k € | +8.6% | 8,2 k € | +5.5% | 7,8 k € | -0.5% | 7,8 k € | -73.7% | 29,9 k € | +43.1% | 20,9 k € | -8.8% | 22,9 k € | +81.1% | 12,6 k € | -92.6% | 169,7 k € | +38.4% | 122,6 k € | -41.3% | 208,8 k € | +5.0% | 198,8 k € | +32.0% | 150,6 k € | |
| Debts | 12,6 M € | +41.8% | 8,9 M € | +1.3% | 8,7 M € | +72.3% | 5,1 M € | -18.4% | 6,2 M € | -52.2% | 13,0 M € | -13.6% | 15,0 M € | +26.3% | 11,9 M € | -12.3% | 13,6 M € | +75.6% | 7,7 M € | +467.2% | 1,4 M € | -11.0% | 1,5 M € | +101.4% | 760,4 k € | +34.7% | 564,7 k € | |
| Staff | 15,1 | 16 | 18 | 19,8 | 20,3 | 20 | 20,3 | 20,5 | 18,3 | 12,9 | 5,7 | 5,3 | 4,8 | 4,5 | ||||||||||||||
Public limited company · Dilbeek · incorporated on 25/06/1996 · 15,1 ETP
Public limited company profitable and well capitalised. Cash position rising (+181.9%).
Solid counterparty for a standard engagement.
SONOVA BELGIUM is a Public limited company incorporated in 1996. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Dilbeek. It employs on average 15,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette